POZIS (part of the Techmash concern of Rostec State Corporation) has increased export of refrigeration and medical equipment by 43% in the first 5 months of this year compared to the same period of 2018. The principal export destination is the CIS, and the company intends to expand its supply geography.
POZIS household refrigerators are in high demand in foreign markets – over the 5 months of this year, their sales increased by almost one-half compared to the same period last year. The most popular export models are double-chamber refrigerators, which account for about 60% of all exports. Pharmaceutical refrigerators and recirculating irradiators also enjoy great demand.
“The development of high-tech civilian products is one of Rostec’s priority areas, on which the State Corporation places particular emphasis. POZIS refrigeration equipment is successfully used by households, as well as medical institutions in many countries around the world. We intend to expand the supply geography of POZIS refrigerators, which have an excellent price-quality ratio and are of genuine interest to our foreign partners,” noted Viktor Kladov, Director of International cooperation and regional policy at Rostec.
Today POZIS is one of the leaders of the Russian military-industrial complex in terms of developing high-tech, export-oriented civilian production. Over 90% of the company’s civilian products account for refrigeration, professional and medical equipment. POZIS is the first and the only Russian serial manufacturer of pharmaceutical refrigerators and specialized refrigerating equipment used for storing blood and plasma.
“The consistently high demand for our refrigeration equipment is not accidental. POZIS products meet European and international quality standards. We acknowledge the utmost responsibility for their manufacture bearing in mind that they have Made in Russia marking of the Russian Export Center,” noted POZIS CEO Radik Khasanov.
Rostec continues to implement a large-scale program for the development of its civilian production in accordance with the approved Strategy, which is mainly aimed at increasing the annual revenue by an average of 17% in ruble terms through to the year 2025, up to 50% growth of the share of civilian products in its revenue, as well as at improving the operating efficiency and gaining access to world markets.
